home > drugs a-z list > gleevec (imatinib mesylate) drug center

Recommended Topic Related To:

Gleevec

Leukemia facts

  • Leukemia is a cancer of the blood cells.
  • While the exact cause(s) of leukemia is not known, risk factors have been identified.
  • Leukemias are grouped by how quickly the disease develops (acute or chronic) as well as by the type of blood cell that is affected (lymphocytes or myelocytes). The four main types of leukemia include acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelocytic leukemia (AML), and chronic myelocytic leukemia (CML).
  • People with leukemia are at significantly increased risk for developing infections, anemia, and bleeding. Other symptoms and signs include easy bruising, weight loss, night sweats, and unexplained fevers.
  • The diagnosis of leukemia is supported by findings of the medical history and examination, and examining blood and bone marrow samples under a microscope.

  • Tre...

Gleevec

font size

Gleevec Drug Center

Medical Editor: Charles Patrick Davis, MD, PhD

Gleevec (imatinib mesylate) is a kinase inhibitor that inhibits a protein signal that causes cancer cell proliferation. It is used to treat patients with hematological malignancies or malignant sarcomas such as Philadelphia positive chronic myeloid leukemia, chronic myeloid leukemia in blast crisis, acute lymphoblastic leukemia, aggressive systemic mastocytosis, gastrointestinal stromal tumors, and other diseases. The generic name for Gleevec is imatinib mesylate and is available outside of the US as a generic named imatinib. Common side effects if Gleevec are mild gastrointestinal symptoms of nausea, diarrhea, gas, muscle and/or joint discomfort, tired, mild skin rash, and flu-like symptoms.

Gleevec is supplied in 100 or 400 mg tablets. The dose is quite variable and depends on the disease being treated, age of patient (some doses based on mg per kilogram weight (mg/Kg). Doses usually range between 100 to 800 mg per day; high doses are divided into lower mg levels but are taken twice a day. Because the tablets have iron in the coating, high doses should use the 400 mg tablets to avoid getting too much iron. Gleevec should be taken with water and food. Gleevec should not be crushed or come in direct contact with skin as serious rashes may develop. Serious side effects can be severe blistering skin rashes, jaundice, gastrointestinal bleeding, weakness with shortness of breath, severe headaches, swelling, and severe flu-like symptoms. Development of these symptoms requires urgent medical evaluation. Gleevec should only be used under the guidance of a physician experienced in treating patients with malignant diseases. It is not safe to use this drug while pregnant; breastfeeding studies are unavailable. Use in children under the age of 18 is infrequent; consultation with a specialist (such as a pediatric oncologist) is recommended. Many medical conditions and drugs affect the levels of Gleevec in patients, so patients are urged to be sure the treating doctor has a complete medical history and medication list before the drug is prescribed.

Our Gleevec Drug Center provides a comprehensive view of available drug information as well as related drugs, user reviews, supplements, and diseases, and conditions.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Gleevec Prescribing Information: Indications & Dosage

GLEEVEC (imatinib mesylate) Structural Formula Illustration

Newly Diagnosed Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML)

Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase.

Ph+ CML in Blast Crisis (BC), Accelerated Phase (AP) or Chronic Phase (CP) After Interferon-alpha (IFN) Therapy

Patients with Philadelphia chromosome positive chronic myeloid leukemia in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.

Ph+ Acute Lymphoblastic Leukemia (ALL)

Adult patients wit...

Read the complete drug monograph for Gleevec »

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Gleevec Patient Information: Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have any of these serious side effects:

  • fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
  • nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
  • fever, chills, body aches, flu symptoms;
  • black, bloody, or tarry stools;
  • coughi...

Read the complete patient information for Gleevec »

What is Consumer information?

A concise overview of the drug for the patient or caregiver from First DataBank.

Gleevec Consumer Information: Uses

This medication is used to treat certain types of cancer (e.g., chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Imatinib works by stopping or slowing the growth of cancer cells (tumors). It also works by causing cancer cells to die.

HOW TO USE: Take this medication by mouth with a meal and a full glass of water (8 ounces or 240 milliliters), usually once or twice daily or as directed by your doctor. The US manufacturer recommends that if you have trouble swallowing the tablets whole, you m...

Read the complete consumer information for Gleevec »

What is Gleevec Consumer Information?

Warnings - Uses - How to Use - Side Effects - Precautions - Drug Interactions and More

Gleevec - User Reviews

Gleevec User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Gleevec sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.